The United Laboratories International Holdings Limited

中/EN
中文繁體 English
  • Investor Relations
    IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
  • Corporate
Investor Relations
  • IR Home
  • Corporate Overview
  • Financial Highlights
  • Financial Reports
  • ESG Reports
  • Regulatory Filings
  • Press Releases
  • Company
    Presentations
  • Stock Quotes &
    Charts
  • Analyst Coverage
  • FAQs
  • IR Contact

Latest News

JUL
16
RECEIVED MILESTONE PAYMENT FROM NOVO NORDISK FOR EXCLUSIVE LICENSE AGREEMENT OF UBT251
JUL
14
APPROVAL FOR MARKETING OF THE GROUP'S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION
JUL
06
Next Day Disclosure Return - Cancellation of Shares Repurchased

2025

Annual Report
PDF | eBook

ESG Report 2025

  • Environment
  • Social
  • Governance

Presentation

Investor Information

  • Regulatory Filings
  • Corporate Governance
  • Stock Quotes & Charts
  • FAQs

IR Contact

6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong
tulir@tul.com.hk
Disclaimer | Sitemap

Copyright © 2026 The United Laboratories International Holdings Limited. All rights reserved.